Cargando…
Reduced uptake of mass treatment for schistosomiasis control in absence of food: beyond a randomized trial
BACKGROUND: Sustaining high uptake of praziquantel is key for long-term control of schistosomiasis. During mass treatment in 2013, we randomized 12 primary schools into two groups; one group received education messages for schistosomiasis prevention for two months prior to mass treatment, while the...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606967/ https://www.ncbi.nlm.nih.gov/pubmed/26466681 http://dx.doi.org/10.1186/s12879-015-1158-7 |
_version_ | 1782395447781883904 |
---|---|
author | Muhumuza, Simon Olsen, Annette Katahoire, Anne Nuwaha, Fred |
author_facet | Muhumuza, Simon Olsen, Annette Katahoire, Anne Nuwaha, Fred |
author_sort | Muhumuza, Simon |
collection | PubMed |
description | BACKGROUND: Sustaining high uptake of praziquantel is key for long-term control of schistosomiasis. During mass treatment in 2013, we randomized 12 primary schools into two groups; one group received education messages for schistosomiasis prevention for two months prior to mass treatment, while the other, in addition to the education messages, received a pre-treatment snack shortly before mass treatment. The uptake of praziquantel in the snack schools was 94 % compared to 79 % in the non-snack schools. During mass treatment in 2014, no snack was provided. We compared the uptake of praziquantel in 2014 to that in 2013 and attempt to explain the reasons for the observed differences. METHODS: Serial cross sectional surveys were conducted among a random sample of children from the 12 primary schools, 1 month after mass treatment in 2013 and 2014 to measure uptake of praziquantel, reported side effects attributable to praziquantel and prevalence and intensity of schistosomiasis infection. Differences in the demographic and descriptive variables between the 2013 and 2014 samples were compared using chi squared tests for categorical variables and student’s t-test for geometric mean intensity of S. mansoni infection. RESULTS: Uptake of praziquantel reduced from 93.9 to 78.0 % (p = 0.002) in the snack schools but was unchanged in the non-schools 78.7 and 70.4 % (p = 0.176). The occurence of side-effects attributable to praziquantel increased from 34.4 to 61.2 % (p = 0.001) in the snack schools but was unchanged in the non-snack schools; 46.9 and 53.2 % (p = 0.443). Although the prevalence of S. mansoni infection increased in both the snack and non-snack schools, the differences did not reach statistical significance;1.3 and 7.5 % (p = 0.051) and 14.1 and 22.0 % (p = 0.141), respectively. Similarly, the difference in the geometric mean intensity of S. mansoni infection in both the snack and non-snack schools was not statistically significant; 38.3 eggs per gram of stool (epg) and 145.7 epg (p = 0.197) and 78.4 epg and 322.5 epg (p = 0.120), respectively. CONCLUSION: Our results show that in absence of food, uptake of praziquantel reduced and the side-effects of the drug increased. However, the reduced uptake did not affect the prevalence and intensity of schistosomiasis among school children. Rescinding of the provision of the snack is what probably caused the reduction in uptake of treatment in the subsequent mass treatment cycle. |
format | Online Article Text |
id | pubmed-4606967 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46069672015-10-16 Reduced uptake of mass treatment for schistosomiasis control in absence of food: beyond a randomized trial Muhumuza, Simon Olsen, Annette Katahoire, Anne Nuwaha, Fred BMC Infect Dis Research Article BACKGROUND: Sustaining high uptake of praziquantel is key for long-term control of schistosomiasis. During mass treatment in 2013, we randomized 12 primary schools into two groups; one group received education messages for schistosomiasis prevention for two months prior to mass treatment, while the other, in addition to the education messages, received a pre-treatment snack shortly before mass treatment. The uptake of praziquantel in the snack schools was 94 % compared to 79 % in the non-snack schools. During mass treatment in 2014, no snack was provided. We compared the uptake of praziquantel in 2014 to that in 2013 and attempt to explain the reasons for the observed differences. METHODS: Serial cross sectional surveys were conducted among a random sample of children from the 12 primary schools, 1 month after mass treatment in 2013 and 2014 to measure uptake of praziquantel, reported side effects attributable to praziquantel and prevalence and intensity of schistosomiasis infection. Differences in the demographic and descriptive variables between the 2013 and 2014 samples were compared using chi squared tests for categorical variables and student’s t-test for geometric mean intensity of S. mansoni infection. RESULTS: Uptake of praziquantel reduced from 93.9 to 78.0 % (p = 0.002) in the snack schools but was unchanged in the non-schools 78.7 and 70.4 % (p = 0.176). The occurence of side-effects attributable to praziquantel increased from 34.4 to 61.2 % (p = 0.001) in the snack schools but was unchanged in the non-snack schools; 46.9 and 53.2 % (p = 0.443). Although the prevalence of S. mansoni infection increased in both the snack and non-snack schools, the differences did not reach statistical significance;1.3 and 7.5 % (p = 0.051) and 14.1 and 22.0 % (p = 0.141), respectively. Similarly, the difference in the geometric mean intensity of S. mansoni infection in both the snack and non-snack schools was not statistically significant; 38.3 eggs per gram of stool (epg) and 145.7 epg (p = 0.197) and 78.4 epg and 322.5 epg (p = 0.120), respectively. CONCLUSION: Our results show that in absence of food, uptake of praziquantel reduced and the side-effects of the drug increased. However, the reduced uptake did not affect the prevalence and intensity of schistosomiasis among school children. Rescinding of the provision of the snack is what probably caused the reduction in uptake of treatment in the subsequent mass treatment cycle. BioMed Central 2015-10-14 /pmc/articles/PMC4606967/ /pubmed/26466681 http://dx.doi.org/10.1186/s12879-015-1158-7 Text en © Muhumuza et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Muhumuza, Simon Olsen, Annette Katahoire, Anne Nuwaha, Fred Reduced uptake of mass treatment for schistosomiasis control in absence of food: beyond a randomized trial |
title | Reduced uptake of mass treatment for schistosomiasis control in absence of food: beyond a randomized trial |
title_full | Reduced uptake of mass treatment for schistosomiasis control in absence of food: beyond a randomized trial |
title_fullStr | Reduced uptake of mass treatment for schistosomiasis control in absence of food: beyond a randomized trial |
title_full_unstemmed | Reduced uptake of mass treatment for schistosomiasis control in absence of food: beyond a randomized trial |
title_short | Reduced uptake of mass treatment for schistosomiasis control in absence of food: beyond a randomized trial |
title_sort | reduced uptake of mass treatment for schistosomiasis control in absence of food: beyond a randomized trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606967/ https://www.ncbi.nlm.nih.gov/pubmed/26466681 http://dx.doi.org/10.1186/s12879-015-1158-7 |
work_keys_str_mv | AT muhumuzasimon reduceduptakeofmasstreatmentforschistosomiasiscontrolinabsenceoffoodbeyondarandomizedtrial AT olsenannette reduceduptakeofmasstreatmentforschistosomiasiscontrolinabsenceoffoodbeyondarandomizedtrial AT katahoireanne reduceduptakeofmasstreatmentforschistosomiasiscontrolinabsenceoffoodbeyondarandomizedtrial AT nuwahafred reduceduptakeofmasstreatmentforschistosomiasiscontrolinabsenceoffoodbeyondarandomizedtrial |